study on the clinical characteristics, intestinal microbial composition and standardized diagnosis and treatment of intestinal bacterial overgrowth in elderly military health care population

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046043

Enrollment

Unknown

Registered

2021-05-02

Start date

2021-05-10

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small intestinal bacterial overgrowth

Interventions

group 1:probiotics

group 2:metronidazole

group 3:rifaximin

Eligibility

Sex/Gender

All

Age

40 Years to No maximum

Inclusion criteria

Inclusion criteria: Elderly patients attending gastroenterology department of the Second Medical Center of PLA General Hospital.

Exclusion criteria

Exclusion criteria: 1. Patients with inflammatory bowel disease, microscopic colitis, tumors, active inflammation, immune diseases, severe systemic, heart, kidney, liver, metabolic diseases, and mental and psychological diseases; 2. Patients who have used antibiotics in the past 4 weeks and gastrointestinal motility drugs, laxatives and probiotics in the past 1 week; 3. Patients who cannot tolerate endoscopy.

Design outcomes

Primary

Measure	Time frame
lactulose breath testing;symptom improvement;	—

Countries

China

Contacts

Public ContactWan Jun

PLA General Hospital

wanjun301@126.com+86 13126672735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026